DocDollars

Amryt Pharma Holdings Ltd

Ireland · Reporting entity ID 100000576811

Total reported 2019–2025
$11.8M
#446 of 2,960 reporting companies — 0% of all reported industry payments
$9.01M in general payments across 5,879 records, plus $2.79M in research funding across 1,663 records.

How it breaks down

General payments $9,013,444
Research funding $2,794,422

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Amryt Pharma Holdings Ltd reported $11.8M to US doctors and teaching hospitals from 2019 to 2025, ranking #446 of 2,960 reporting companies. 24% of that was research funding and 76% general payments such as consulting, speaking, food and travel. 5,879 general payment records and 1,663 research records were filed.

Common questions about Amryt Pharma Holdings Ltd

How much has Amryt Pharma Holdings Ltd paid US doctors?

Amryt Pharma Holdings Ltd reported $11,807,866 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $9,013,444 in general payments, $2,794,422 in research funding.

How does Amryt Pharma Holdings Ltd rank among drug and device companies?

It ranks #446 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Amryt Pharma Holdings Ltd mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.